|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||2.7131 - 2.8300|
|52 Week Range||0.1000 - 4.7400|
|Beta (5Y Monthly)||-0.10|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Picture 1 In a video segment on the Company’s YouTube channel, CEO Setti Coscarella explains the three main strategic considerations behind the Q1 2021 launch of the TAAT™ e-commerce portal, which along with the TryTAAT landing page could play a significant role in establishing TAAT™ as a memorable product and brand among smokers aged 21+ across the United States. Based on feedback from a consumer study conducted earlier this year, the Company launched a new advertisement campaign for TryTAAT, a landing page through which smokers aged 21+ in the United States can request a free sample pack of TAAT™. When TryTAAT was first launched in November 2020, nearly one third of visitors submitted qualified sample requests, which far exceeded average conversion rates for landing pages. Over 5,000 new qualified requests have been submitted on TryTAAT since Wednesday, March 24, 2021. The Company intends to continue this campaign as part of its overall strategy for encouraging product trials and cultivating brand awareness. LAS VEGAS and VANCOUVER, British Columbia, March 26, 2021 (GLOBE NEWSWIRE) -- TAAT™ LIFESTYLE & WELLNESS LTD. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2) (the “Company” or “TAAT™”) is pleased to announce that using feedback collected from a recent consumer study about TAAT™, the Company began a new online advertisement campaign on Wednesday targeted towards smokers aged 21+ in the United States with an objective of prompting requests for a complimentary pack of TAAT™ Original, Smooth, or Menthol on the TryTAAT landing page (http://trytaat.com). As of Friday, March 26, 2021, more than 5,000 new qualified sample requests have been received by the Company from users in all eligible1 U.S. states, with fulfillment of these requests set to begin during the week of Monday, March 29, 2021. In a press release dated November 6, 2020, the Company announced that it launched TryTAAT in advance of in-store availability of TAAT™ at tobacco points of sale in Ohio as a strategy to promote early-stage interest in the product among smokers aged 21+. Between Q4 2020 and Q1 2021 the Company has deployed several initiatives in relation to the launch of TAAT™ including in-house sales efforts, engaging a national sales agency that directly services more than 100,000 convenience stores in the United States, purchasing video advertisement slots on a network of several thousand gas pump displays across Ohio, and opening an e-commerce portal through which the majority of smokers aged 21+ in the United States can purchase TAAT™ online. The Company’s current objective is to prompt a high trial rate of TAAT™ products both to cultivate large-scale awareness and to gather feedback from smokers aged 21+ in various markets. In a recent video segment, TAAT™ Chief Executive Officer Setti Coscarella explained the three main strategic considerations behind launching the e-commerce portal alongside the existing channels through which TAAT™ can be procured, one of which is the ability to gather market research data to prioritize prospective markets for potential retail expansions in the future. This video segment can be viewed by clicking here. To view Picture 1 accompanying this release please visit:https://www.globenewswire.com/NewsRoom/AttachmentNg/66293cd0-abcd-4031-9199-f7466f4c6bbc In a video segment on the Company’s YouTube channel, CEO Setti Coscarella explains the three main strategic considerations behind the Q1 2021 launch of the TAAT™ e-commerce portal, which along with the TryTAAT landing page could play a significant role in establishing TAAT™ as a memorable product and brand among smokers aged 21+ across the United States. To view the full video, please click here. Readers using news aggregation services may be unable to view the media above. Please access SEDAR or the Investor Relations section of the Company’s website for a version of this press release containing all published media. Earlier in Q1 2021, the Company commissioned a consumer feedback study which included a sample of 176 smokers aged 21+ in Ohio who were each given a carton of TAAT™ to sample at home. On average, 57% of respondents stated they “Definitely Would” or “Probably Would” purchase TAAT™ in the future at its current price point, with 68% of subjects who sampled TAAT™ Menthol selecting such responses. These insights played a significant role in the formation of the advertisement model that the Company began to use this week, reflecting the importance of collecting and acting upon consumer feedback in each new iteration of TAAT™’s launch. The Company intends to continue availing packs of TAAT™ across the United States through various channels to passively grow awareness of the brand and gather insights from smokers aged 21+ which could provide useful metrics for the optimization of potential future launches in new markets. TAAT™ Chief Executive Officer Setti Coscarella commented, “We have achieved great momentum so far among smokers in the United States as many have come to recognize TAAT™ as a better choice compared to traditional tobacco cigarettes. This has been done through a combination of passive awareness campaigns targeted towards smokers aged 21+, as well as promotions to prompt purchases on the e-commerce portal or to request a free sample pack on TryTAAT. Our goal with the latter two initiatives is to get ‘pack in hand’. No matter how informative our messaging and user testimonials may be, we firmly believe that after a smoker aged 21+ has sampled TAAT™, a certain percentage will be persuaded into purchasing it regularly based on a positive experience. This sentiment was shared by the majority of respondents in our consumer feedback study, especially those who sampled TAAT™ Menthol. Now that we have a better idea of what works best, we are ramping up our advertising to drive traffic to TryTAAT and have seen spectacular results so far with more than 5,000 new qualified sample requests submitted since Wednesday. By continuing with this strategy we believe we can cover more ground among approximately 40 million tobacco smokers in the U.S. so that they can know about and have access to a better choice.” Sources 1 - Because the legal status of TAAT™ can vary between jurisdictions, the Company can only accept and fulfil orders and sample requests for TAAT™ made online with shipping addresses in jurisdictions that have been approved by the Company's legal counsel. On behalf of the Board of Directors of the Company, TAAT™ LIFESTYLE & WELLNESS LTD. “Setti Coscarella” Setti Coscarella, CEO and Director For further information, please contact: TAAT™ Investor Relations1-833-TAAT-USA (1-833-822-8872)email@example.com THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE’S REGULATION SERVICES PROVIDER. About TAAT™ Lifestyle & Wellness Ltd. The Company has developed TAAT™, which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in "Original", "Smooth", and "Menthol" varieties. TAAT™'s base material is Beyond Tobacco™, a proprietary blend which undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with "Big Tobacco" pedigree, TAAT™ was launched first in the United States in Q4 2020 as the Company seeks to position itself in the $814 billion1 global tobacco industry. For more information, please visit http://taatglobal.com. References 1 British American Tobacco - The Global Market Forward-Looking Statements This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking information and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur, or be achieved. Forward-looking information in this news release includes statements regarding the potential launch of Beyond Tobacco™, in addition to the following: Potential outcomes from TAAT™ sample requests made by smokers aged 21+, future performance of TAAT™ in the United States. The forward-looking information reflects management’s current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in preparing the forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed timeframes or at all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes to the growth and size of the tobacco markets; and (iii) other factors beyond the control of the Company. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking information. The forward-looking information included in this news release are made as of the date of this news release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law. The statements in this news release have not been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claims or guarantees can be made as to the effects of the Company’s products on an individual’s health and well-being. The Company’s products are not intended to diagnose, treat, cure, or prevent any disease. This news release may contain trademarked names of third-party entities (or their respective offerings with trademarked names) typically in reference to (i) relationships had by the Company with such third-party entities as referred to in this release and/or (ii) client/vendor/service provider parties whose relationship with the Company is/are referred to in this release. All rights to such trademarks are reserved by their respective owners or licensees. Statement Regarding Third-Party Investor Relations Firms Disclosures relating to investor relations firms retained by TAAT™ Lifestyle & Wellness Ltd. can be found under the Company's profile on http://sedar.com.
VANCOUVER, British Columbia, March 26, 2021 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE:CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) is pleased to announce that Salvatore Milia has been appointed to the Company’s Board of Directors, effective immediately. In a press release dated January 8, 2021, CLC announced that Mr. Milia had received clearance from Health Canada to enter this capacity with the official appointment pending, which was finalized this week. Mr. Milia is currently leading the Company’s research and development committee that was recently formed under his leadership. Mr. Milia has a background in building large-scale information technology systems, an acumen that can be applied to CLC’s plans to incorporate smart monitoring technology into its vertically integrated cannabis cultivation workflows. Having designed, implemented, and managed technical systems and networks for one of Canada’s first non-bank credit card gateways as well as for a major Canadian political party, the Company’s management believes Mr. Milia’s experience with infrastructures in sensitive and highly regulated environments could help CLC in further improving its crop yields and consistency while maintaining compliance with all applicable regulations. In a press release dated February 26, 2021, CLC announced that it had entered into a memorandum of understanding (“MOU”) with TAAT™ Lifestyle & Wellness Ltd. (“TAAT™”) (CSE: TAAT) in which the Company is to become the exclusive developer and distributor of TAAT™’s tobacco-free and nicotine-free alternative to tobacco cigarettes. CLC has assigned Mr. Milia to lead research and development efforts relating to the Company’s production of TAAT™ and its Beyond Tobacco™ base material for the Canadian market. This responsibility is expected to include tasks such as collaborating with TAAT™’s research and development team in Las Vegas, NV, performing an analysis of the Canadian market for alternatives to tobacco cigarettes, and preparing compliance-related documentation for submission to Health Canada and other agencies. More information about TAAT™ can be found on its website: http:///taatglobal.com. The Company also announces that Mr. Jason Taylor has resigned from its Board of Directors effective immediately. The Company wishes to thank Mr. Taylor for his contributions to the Company during its early years and wishes him well with his future endeavours. Joel Dumaresq, Chief Executive Officer and a Director of the Company commented, “We are thrilled to announce Mr. Milia’s appointment to our Board of Directors and look forward to tapping into his technological and systems management expertise to optimize and automate certain aspects of our crop development to consistently produce top-quality sun-grown cannabis. With the addition of TAAT™ as a partner for whom we intend to produce their product line for the Canadian market, we are pleased to have Mr. Milia’s acumen on our side as we seek to add another exciting dimension to our business model.” About Christina Lake Cannabis Corp. Christina Lake Cannabis Corp. is a licensed producer of cannabis under the Cannabis Act. It has secured a standard cultivation licence and corresponding processing/sales amendment from Health Canada (March 2020 and August 2020, respectively) as well as a research and development licence (early 2020). CLC’s facility consists of a 32-acre property, which includes over 950,000 square feet of outdoor grow space, offices, propagation and drying rooms, research facilities, and a facility dedicated to processing and extraction. CLC also owns a 99-acre plot of land adjoining its principal 32-acre site, which enables the Company to grow at a much larger scale. CLC cultivates cannabis using strains specifically developed for outdoor cultivation and in its inaugural harvest year produced 32,500 kg (71,650 lb) on its existing facility before developing an adjacent 99-acre expansion property. Such an expansion will ultimately bring CLC’s annual cultivation footprint to over 4.35 million square feet, which could enable at least 150,000 kg (330,693 lb) of low-cost, high-quality, sun-grown cannabis to be produced annually by the Company. On behalf of Christina Lake Cannabis Corp.: “Joel Dumaresq” Joel Dumaresq, CEO and Director For more information about CLC, please visit: www.christinalakecannabis.com Jamie FrawleyInvestor Relations and Media Inquiriesjamie@clcannabis.com 416-268-9432 THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE’S REGULATION SERVICES PROVIDER. Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements.” The use of any of the words “anticipate,” “continue,” “estimate,” “expect,” “may,” “will,” “would,” “project,” “should,” “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on http://www.sedar.com. Statement Regarding Third-Party Investor Relations Firms Disclosure relating to investor relations firms retained by Christina Lake Cannabis Corp. can be found under the Company's profile on http://sedar.com.
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced TAAT™ Lifestyle & Wellness Ltd. (CSE: TAAT; OTCQX: TOBAF), the innovator of a nicotine-free and tobacco-free alternative to tobacco cigarettes, has qualified to trade on the OTCQX® Best Market. TAAT™ Lifestyle & Wellness Ltd. upgraded to OTCQX from the OTCQB® Venture Market.